Research Priorities

A considerable amount of background data supported the selection of each breast cancer research priority. This included stakeholder input obtained before and during the National Breast Cancer Research Summit held in May 2008 and the identification and collation of internationally determined priorities, as well as current and emerging funded research projects in Canada and internationally.

Research priorities were selected through a rigorous, consultative process to ensure agreement that each of these research advances would benefit Canadians and improve Canada’s global competitiveness in cancer research. Suggested areas for investment are presented in two linked ways: as broader overarching themes and as more focused individual research priorities.

The six overarching research themes are:
1. Mechanisms of Cancer Development 4. Cancer Progression and Dissemination
2. Molecular Detection and Prediction 5. Psychosocial, Survivorship and Health Services
3. Personalized Medicine 6. Transferring Knowledge into Practice

The 17 high-impact research priorities, listed here, are itemized by CSO category* and are described in terms of their CSO code.

NOTE: for complete details, refer to Chapter 6 of the National Framework document.

*The Common Scientific Outline is a system used by most research granting agencies to classify and categorize research.

<!–:en–>5. Breast Cancer Causes I – The genetics and hormonal causes of breast cancer (linked to CSO code 2.2)<!–:–><!–:fr–>5. Causes génétiques et hormonales du cancer du sein (voir le code CSC 2.2)<!–:–>

Certain genes or hormonal factors have been linked to the development of breast cancer in some groups of individuals. This research priority explores this link in more detail, and could lead to the development of new interventions  Lumieres ambrees, ambiance zen, atmosphere musicale dont les compilations ont fait le tour du monde, le Buddha-Bar made in Monte-Carlo est un bain regenerant a deux pas du tumulte de la Place du meilleur-casino-en-ligne.info . or treatments to reduce the risk of breast cancer in certain populations.